136 related articles for article (PubMed ID: 7909871)
21. p53 protein accumulation and mutations in normal and benign breast tissue.
Kandel R; Li SQ; Ozcelik H; Rohan T
Int J Cancer; 2000 Jul; 87(1):73-8. PubMed ID: 10861455
[TBL] [Abstract][Full Text] [Related]
22. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R
Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151
[TBL] [Abstract][Full Text] [Related]
23. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
[TBL] [Abstract][Full Text] [Related]
24. p53 mutations and overexpressions in Japanese breast cancer.
Fukushima T; Onda M; Abe R; Otake T; Kimijima I; Tsuchiya A
Eur J Surg Oncol; 1995 Dec; 21(6):595-600. PubMed ID: 8631401
[TBL] [Abstract][Full Text] [Related]
25. TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis.
Olivier M; Hainaut P
Semin Cancer Biol; 2001 Oct; 11(5):353-60. PubMed ID: 11562177
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
27. p53 mutations and overexpression in locally advanced breast cancers.
Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
[TBL] [Abstract][Full Text] [Related]
28. p53 as a mutagen test in breast cancer.
Hill KA; Sommer SS
Environ Mol Mutagen; 2002; 39(2-3):216-27. PubMed ID: 11921192
[TBL] [Abstract][Full Text] [Related]
29. Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample.
van Rensburg EJ; Engelbrecht S; van Heerden WF; Kotze MJ; Raubenheimer EJ
Hum Mutat; 1998; 11(1):39-44. PubMed ID: 9450901
[TBL] [Abstract][Full Text] [Related]
30. Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France.
Preudhomme C; Fenaux P; Peyrat JP; Fournier J; Bonneterre J; Vennin P
Eur J Cancer; 1993; 29A(10):1476-8. PubMed ID: 8398277
[TBL] [Abstract][Full Text] [Related]
31. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.
Caleffi M; Teague MW; Jensen RA; Vnencak-Jones CL; Dupont WD; Parl FF
Cancer; 1994 Apr; 73(8):2147-56. PubMed ID: 8156519
[TBL] [Abstract][Full Text] [Related]
32. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
33. P53 gene mutations in women with breast cancer and a previous history of benign breast disease.
Seth A; Palli D; Mariano JM; Metcalf R; Venanzoni MC; Bianchi S; Kottaridis SD; Papas TS
Eur J Cancer; 1994; 30A(6):808-12. PubMed ID: 7917542
[TBL] [Abstract][Full Text] [Related]
34. p53 mutations occur in aggressive breast cancer.
Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
36. Absence of p53 germ-line mutations in bilateral breast cancer patients.
Lidereau R; Soussi T
Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
[TBL] [Abstract][Full Text] [Related]
37. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
38. Waf-1 (p21) and p53 polymorphisms in breast cancer.
Keshava C; Frye BL; Wolff MS; McCanlies EC; Weston A
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):127-30. PubMed ID: 11815410
[TBL] [Abstract][Full Text] [Related]
39. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
40. p53 alterations in all stages of breast cancer.
Davidoff AM; Kerns BJ; Pence JC; Marks JR; Iglehart JD
J Surg Oncol; 1991 Dec; 48(4):260-7. PubMed ID: 1745051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
